FENC
FENNEC PHARMACEUTICALS INC.
+0.30 (+2.84%)10.85USD34.7K成交股數380M市值–本益比(近四季)6.4股價營收比+85.2%營收年增(近四季)2026-11-12下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 6 · 1.5M · 4 |
| 其中 10b5-1 計畫賣出 | 5 筆 |
| 近 180 天 買進 · 賣出金額 | 0 · 1.8M |
| 近 180 天 淨額 | −1.8M |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-15 | 09-17 | Brughera Marco Maria | Director | S 公開市場賣出(10b5-1) | 15.5K | 10.29 | 160K | 0 | SEC |
| 2026-09-15 | 09-17 | Brughera Marco Maria | Director | M 選擇權執行 | 15.5K | 2.11 | 33K | 15.5K | SEC |
| 2026-09-01 | 09-01 | Raykov Rosty | Other | S 公開市場賣出(10b5-1) | 10.0K | 12.11 | 121K | 124K | SEC |
| 2026-08-31 | 09-01 | Raykov Rosty | Other | A 獲配股票 | 2.8K | – | – | 134K | SEC |
| 2026-08-31 | 08-31 | Andrade Robert | CHIEF FINANCIAL OFFICER | A 獲配股票 | 1.7K | – | – | 241K | SEC |
| 2026-08-31 | 08-31 | Hackman Jeffrey S. | Chief Executive Officer | A 獲配股票 | 1.2K | – | – | 66.3K | SEC |
| 2026-08-31 | 08-31 | Sayad Pierre Sargis | Chief Medical Officer | A 獲配股票 | 168 | – | – | 21.5K | SEC |
| 2026-08-31 | 08-31 | Cioffi Christiana Marie | Chief Strategy Officer | A 獲配股票 | 156 | – | – | 24.6K | SEC |
| 2026-08-31 | 08-31 | Evans Terry L | Chief Commercial Officer | A 獲配股票 | 168 | – | – | 21.5K | SEC |
| 2026-08-31 | 08-31 | Sayad Pierre Sargis | Chief Medical Officer | S 公開市場賣出 | 12.0K | 12.18 | 146K | 9.5K | SEC |
| 2026-08-28 | 08-28 | Andrade Robert | CHIEF FINANCIAL OFFICER | M 選擇權執行 | 21.9K | 5.10 | 112K | 240K | SEC |
| 2026-08-27 | 08-28 | Andrade Robert | CHIEF FINANCIAL OFFICER | S 公開市場賣出(10b5-1) | 75.0K | 11.78 | 884K | 218K | SEC |
| 2026-08-03 | 08-04 | Raykov Rosty | Other | S 公開市場賣出(10b5-1) | 10.0K | 9.58 | 96K | 132K | SEC |
| 2026-07-31 | 08-03 | Evans Terry L | Chief Commercial Officer | A 獲配股票 | 168 | – | – | 21.4K | SEC |
| 2026-07-31 | 08-03 | Cioffi Christiana Marie | Chief Strategy Officer | A 獲配股票 | 156 | – | – | 24.5K | SEC |
| 2026-07-31 | 08-03 | Andrade Robert | CHIEF FINANCIAL OFFICER | A 獲配股票 | 1.7K | – | – | 293K | SEC |
| 2026-07-31 | 08-03 | Raykov Rosty | Other | A 獲配股票 | 2.8K | – | – | 142K | SEC |
| 2026-07-31 | 08-03 | Sayad Pierre Sargis | Chief Medical Officer | A 獲配股票 | 168 | – | – | 21.4K | SEC |
| 2026-07-31 | 08-03 | Hackman Jeffrey S. | Chief Executive Officer | A 獲配股票 | 1.2K | – | – | 65.1K | SEC |
| 2026-07-01 | 07-02 | Raykov Rosty | Other | S 公開市場賣出(10b5-1) | 9.6K | 10.41 | 100K | 139K | SEC |
| 2026-07-01 | 07-02 | Raykov Rosty | Other | M 選擇權執行 | 15.6K | 2.45 | 38K | 148K | SEC |
| 2026-07-01 | 07-02 | Raykov Rosty | Other | A 獲配股票 | 2.8K | – | – | 133K | SEC |
| 2026-06-30 | 07-01 | Sayad Pierre Sargis | Chief Medical Officer | A 獲配股票 | 168 | – | – | 21.2K | SEC |
| 2026-06-30 | 07-01 | Andrade Robert | CHIEF FINANCIAL OFFICER | A 獲配股票 | 1.7K | – | – | 291K | SEC |
| 2026-06-30 | 07-01 | Hackman Jeffrey S. | Chief Executive Officer | A 獲配股票 | 1.2K | – | – | 64.0K | SEC |
| 2026-06-30 | 07-01 | Cioffi Christiana Marie | Chief Strategy Officer | A 獲配股票 | 156 | – | – | 24.3K | SEC |
| 2026-06-30 | 07-01 | Evans Terry L | Chief Commercial Officer | A 獲配股票 | 168 | – | – | 21.2K | SEC |
| 2026-06-01 | 06-02 | Raykov Rosty | Director | S 公開市場賣出(10b5-1) | 9.7K | 9.62 | 94K | 130K | SEC |
| 2026-06-01 | 06-02 | Raykov Rosty | Director | M 選擇權執行 | 15.6K | 2.45 | 38K | 140K | SEC |
| 2026-05-31 | 06-02 | Raykov Rosty | Director | A 獲配股票 | 2.8K | – | – | 124K | SEC |
| 2026-05-31 | 06-01 | Andrade Robert | CHIEF FINANCIAL OFFICER | A 獲配股票 | 1.7K | – | – | 289K | SEC |
| 2026-05-31 | 06-01 | Evans Terry L | Chief Commercial Officer | A 獲配股票 | 168 | – | – | 21.0K | SEC |
| 2026-05-31 | 06-01 | Hackman Jeffrey S. | Chief Executive Officer | A 獲配股票 | 1.2K | – | – | 62.8K | SEC |
| 2026-05-31 | 06-01 | Cioffi Christiana Marie | Chief Strategy Officer | A 獲配股票 | 156 | – | – | 24.2K | SEC |
| 2026-05-31 | 06-01 | Sayad Pierre Sargis | Chief Medical Officer | A 獲配股票 | 168 | – | – | 21.0K | SEC |
| 2026-05-11 | 05-12 | RALLIS CHRIS A | Director | S 公開市場賣出(10b5-1) | 8.3K | 7.04 | 59K | 63.1K | SEC |
| 2026-05-11 | 05-12 | RALLIS CHRIS A | Director | M 選擇權執行 | 14.3K | 2.44 | 35K | 71.4K | SEC |
| 2026-05-01 | 05-01 | Raykov Rosty | Director | S 公開市場賣出(10b5-1) | 10.8K | 6.47 | 70K | 121K | SEC |
| 2026-05-01 | 05-01 | Raykov Rosty | Director | M 選擇權執行 | 15.6K | 2.45 | 38K | 132K | SEC |
| 2026-04-30 | 05-01 | Sayad Pierre Sargis | Chief Medical Officer | M 選擇權執行 | 168 | – | – | 20.8K | SEC |
| 2026-04-30 | 05-01 | Hackman Jeffrey S. | Chief Executive Officer | M 選擇權執行 | 1.2K | – | – | 61.7K | SEC |
| 2026-04-30 | 05-01 | Cioffi Christiana Marie | Chief Strategy Officer | M 選擇權執行 | 155 | – | – | 24.0K | SEC |
| 2026-04-30 | 05-01 | Raykov Rosty | Director | M 選擇權執行 | 2.8K | – | – | 117K | SEC |
| 2026-04-30 | 05-01 | Evans Terry L | Chief Commercial Officer | M 選擇權執行 | 168 | – | – | 20.8K | SEC |
| 2026-04-30 | 05-01 | Andrade Robert | CHIEF FINANCIAL OFFICER | M 選擇權執行 | 1.7K | – | – | 288K | SEC |
| 2026-04-01 | 04-02 | Raykov Rosty | Director | S 公開市場賣出(10b5-1) | 10.9K | 6.31 | 69K | 114K | SEC |
| 2026-04-01 | 04-02 | Raykov Rosty | Director | M 選擇權執行 | 15.6K | 2.45 | 38K | 125K | SEC |
| 2026-03-31 | 04-02 | Cioffi Christiana Marie | Chief Strategy Officer | M 選擇權執行 | 158 | – | – | 22.0K | SEC |
| 2026-03-31 | 04-02 | Cioffi Christiana Marie | Chief Strategy Officer | M 選擇權執行 | 17.1K | – | – | 21.8K | SEC |
| 2026-03-31 | 04-02 | Sayad Pierre Sargis | Chief Medical Officer | M 選擇權執行 | 171 | – | – | 18.6K | SEC |
| 2026-03-31 | 04-02 | Sayad Pierre Sargis | Chief Medical Officer | M 選擇權執行 | 18.5K | – | – | 18.5K | SEC |
| 2026-03-31 | 04-02 | Evans Terry L | Chief Commercial Officer | M 選擇權執行 | 171 | – | – | 18.6K | SEC |
| 2026-03-31 | 04-02 | Evans Terry L | Chief Commercial Officer | M 選擇權執行 | 18.5K | – | – | 18.5K | SEC |
| 2026-03-31 | 04-02 | Hackman Jeffrey S. | Chief Executive Officer | M 選擇權執行 | 16.7K | – | – | 45.4K | SEC |
| 2026-03-31 | 04-02 | Hackman Jeffrey S. | Chief Executive Officer | M 選擇權執行 | 1.2K | – | – | 46.6K | SEC |
| 2026-03-31 | 04-02 | Raykov Rosty | Director | A 獲配股票 | 5.2K | – | – | 109K | SEC |
| 2026-03-31 | 04-02 | Andrade Robert | CHIEF FINANCIAL OFFICER | M 選擇權執行 | 14.7K | – | – | 271K | SEC |
| 2026-03-31 | 04-02 | Andrade Robert | CHIEF FINANCIAL OFFICER | M 選擇權執行 | 2.2K | – | – | 274K | SEC |
| 2026-03-28 | 04-02 | Cioffi Christiana Marie | Chief Strategy Officer | M 選擇權執行 | 1.9K | – | – | 23.9K | SEC |
| 2026-03-28 | 04-02 | Sayad Pierre Sargis | Chief Medical Officer | M 選擇權執行 | 2.1K | – | – | 20.7K | SEC |
| 2026-03-28 | 04-02 | Evans Terry L | Chief Commercial Officer | M 選擇權執行 | 2.1K | – | – | 20.7K | SEC |
| 2026-03-28 | 04-02 | Hackman Jeffrey S. | Chief Executive Officer | M 選擇權執行 | 13.9K | – | – | 60.5K | SEC |
| 2026-03-28 | 04-02 | Andrade Robert | CHIEF FINANCIAL OFFICER | M 選擇權執行 | 12.3K | – | – | 286K | SEC |
| 2026-03-26 | 03-26 | Andrade Robert | CHIEF FINANCIAL OFFICER | M 選擇權執行 | 13.1K | 5.10 | 67K | 257K | SEC |
| 2026-03-26 | 03-26 | Cioffi Christiana Marie | Chief Strategy Officer | M 選擇權執行 | 4.7K | 4.23 | 20K | 4.7K | SEC |
| 2026-03-02 | 03-03 | Raykov Rosty | Director | S 公開市場賣出(10b5-1) | 10.1K | 8.36 | 84K | 104K | SEC |
| 2026-03-02 | 03-03 | Raykov Rosty | Director | M 選擇權執行 | 15.6K | 2.45 | 38K | 114K | SEC |
| 2026-02-28 | 03-03 | Andrade Robert | CHIEF FINANCIAL OFFICER | A 獲配股票 | 1.2K | – | – | 244K | SEC |
| 2026-02-28 | 03-03 | Raykov Rosty | Director | A 獲配股票 | 5.2K | – | – | 109K | SEC |
| 2026-02-18 | 02-19 | Andrade Robert | CHIEF FINANCIAL OFFICER | M 選擇權執行 | 2.5K | 4.08 | 10K | 215K | SEC |
| 2026-02-18 | 02-19 | Hackman Jeffrey S. | Chief Executive Officer | M 選擇權執行 | 13.7K | – | – | 28.7K | SEC |
| 2026-02-18 | 02-19 | Andrade Robert | CHIEF FINANCIAL OFFICER | M 選擇權執行 | 27.3K | – | – | 242K | SEC |
| 2026-02-02 | 02-02 | Raykov Rosty | Director | M 選擇權執行 | 15.6K | 2.45 | 38K | 109K | SEC |
| 2026-02-02 | 02-02 | Raykov Rosty | Director | S 公開市場賣出(10b5-1) | 10.3K | 7.76 | 80K | 98.5K | SEC |
| 2026-01-31 | 02-02 | Raykov Rosty | Director | A 獲配股票 | 5.2K | – | – | 93.2K | SEC |
| 2026-01-31 | 02-02 | Andrade Robert | CHIEF FINANCIAL OFFICER | A 獲配股票 | 1.6K | – | – | 213K | SEC |
| 2026-01-23 | 01-23 | Andrade Robert | CHIEF FINANCIAL OFFICER | M 選擇權執行 | 10.0K | 2.45 | 25K | 211K | SEC |
| 2026-01-15 | 01-15 | Andrade Robert | CHIEF FINANCIAL OFFICER | M 選擇權執行 | 10.0K | 2.45 | 25K | 201K | SEC |
| 2026-01-07 | 01-07 | Andrade Robert | CHIEF FINANCIAL OFFICER | M 選擇權執行 | 14.2K | 2.45 | 35K | 191K | SEC |
| 2026-01-02 | 01-05 | Raykov Rosty | Director | M 選擇權執行 | 15.6K | 2.45 | 38K | 98.3K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| Rosalind Advisors, Inc. | 3.2M | 34.3M | +280K (+10%) | 加碼 |
| AIGH Capital Management LLC | 2.5M | 26.7M | +505K (+25%) | 加碼 |
| Solas Capital Management, LLC | 1.9M | 20.3M | −593K (-24%) | 減碼 |
| BlackRock, Inc. | 1.7M | 18.6M | +359K (+26%) | 加碼 |
| AWM Investment Company, Inc. | 1.2M | 12.5M | +440K (+61%) | 加碼 |
| VANGUARD CAPITAL MANAGEMENT LLC | 839K | 9.0M | −57.8K (-6%) | 減碼 |
| Prospect Capital Advisors, LLC | 498K | 5.4M | 新進 | 新進 |
| STATE STREET CORP | 426K | 4.6M | +66.9K (+19%) | 加碼 |
| GEODE CAPITAL MANAGEMENT, LLC | 403K | 4.3M | +30.8K (+8%) | 加碼 |
| JANE STREET GROUP, LLC | 234K | 2.5M | 新進 | 新進 |
| Potomac Capital Management, Inc. | 224K | 2.4M | 不變 | 持平 |
| MORGAN STANLEY | 222K | 2.4M | +10.8K (+5%) | 加碼 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 200K | 2.1M | +31.5K (+19%) | 加碼 |
| NORTHERN TRUST CORP | 168K | 1.8M | +15.8K (+10%) | 加碼 |
| MARSHALL WACE, LLP | 139K | 1.5M | 新進 | 新進 |
| 文藝復興 RENAISSANCE TECHNOLOGIES LLC | 134K | 1.4M | 新進 | 新進 |
| Nuveen, LLC | 131K | 1.4M | +70.5K (+116%) | 加碼 |
| Trexquant Investment LP | 119K | 1.3M | +67.3K (+130%) | 加碼 |
| CenterBook Partners LP | 119K | 1.3M | 新進 | 新進 |
| Lion Point Capital, LP | 112K | 1.2M | 不變 | 持平 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 108K | 1.2M | +25.0K (+30%) | 加碼 |
| Cornerstone Capital, Inc. | 105K | 1.1M | 不變 | 持平 |
| XTX Topco Ltd | 93.9K | 1.0M | +78.6K (+515%) | 加碼 |
| AQR CAPITAL MANAGEMENT LLC | 92.9K | 999K | +68.7K (+285%) | 加碼 |
| WELLINGTON MANAGEMENT GROUP LLP | 84.5K | 909K | 新進 | 新進 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 105 +15 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 25 / 10 / 44 / 18 |
| 機構合計持股 · 佔流通股 | 16.3M · 46.5% |
| 合計季末市值 | 174M |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 521K |
|---|---|
| 與上期比 | -2.1% |
| 佔流通股數 | 1.48% |
| 日均成交量 | 256K |
| 回補天數 | 2.0 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 521K | -2.1% | 1.48% | 256K | 2.0 |
| 2026-08-14 | 532K | -13.6% | 1.52% | 245K | 2.2 |
| 2026-07-31 | 616K | +1.1% | 1.76% | 116K | 5.3 |
| 2026-07-15 | 609K | +24.6% | 1.74% | 183K | 3.3 |
| 2026-06-30 | 489K | +8.5% | 1.39% | 366K | 1.3 |
| 2026-06-15 | 451K | -9.5% | 1.28% | 225K | 2.0 |
| 2026-05-29 | 498K | -20.1% | 1.42% | 356K | 1.4 |
| 2026-05-15 | 623K | -41.2% | 1.78% | 386K | 1.6 |
| 2026-04-30 | 1.1M | +13.9% | 3.02% | 118K | 9.0 |
| 2026-04-15 | 931K | +1.9% | 2.65% | 177K | 5.3 |
| 2026-03-31 | 913K | +13.2% | 2.60% | 309K | 3.0 |
| 2026-03-13 | 807K | -2.1% | 2.30% | 126K | 6.4 |
| 2026-02-27 | 824K | +1.6% | 2.35% | 116K | 7.1 |
| 2026-02-13 | 812K | +5.5% | 2.31% | 106K | 7.7 |
| 2026-01-30 | 770K | +3.8% | 2.19% | 94.5K | 8.2 |
| 2026-01-15 | 742K | -4.7% | 2.11% | 134K | 5.5 |
| 2025-12-31 | 778K | -9.5% | 2.22% | 212K | 3.7 |
| 2025-12-15 | 859K | -2.6% | 2.45% | 150K | 5.7 |
| 2025-11-28 | 882K | -17.8% | 2.52% | 219K | 4.0 |
| 2025-11-14 | 1.1M | +9.5% | 3.06% | 147K | 7.3 |
| 2025-10-31 | 981K | -25.0% | 2.80% | 71.9K | 13.6 |
| 2025-10-15 | 1.3M | +0.3% | 3.73% | 74.0K | 17.7 |
| 2025-09-30 | 1.3M | -1.8% | 3.72% | 112K | 11.6 |
| 2025-09-15 | 1.3M | +6.5% | 3.79% | 47.9K | 27.7 |
| 2025-08-29 | 1.2M | -2.6% | 3.56% | 63.3K | 19.7 |
| 2025-08-15 | 1.3M | -0.4% | 3.65% | 68.1K | 18.8 |